Management of sudden psychiatric disorders related to efavirenz.
Peyriere
H
H
Mauboussin
J M
JM
Rouanet
I
I
Fabre
J
J
Reynes
J
J
Hillaire-Buys
D
D
D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects*; D048588:Benzoxazines; D003521:Cyclopropanes; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000139:chemically induced*; D010078:Oxazines / Q000009:adverse effects*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz